Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers

David L. Tamang, Waheed Pirzai, Gregory P. Priebe, David C. Traficante, Gerald B. Pier, J R Falck, Christophe Morisseau, Bruce D. Hammock, Beth A. McCormick, Karsten Gronert, Bryan P. Hurley

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A feature shared by many inflammatory lung diseases is excessive neutrophilic infiltration. Neutrophil homing to airspaces involve multiple factors produced by several distinct cell types. Hepoxilin A3 is a neutrophil chemoattractant produced by pathogeninfected epithelial cells that is hypothesized to facilitate neutrophil breach of mucosal barriers. Using a Transwell model of lung epithelial barriers infected with Pseudomonas aeruginosa, we explored the role of hepoxilin A3 in neutrophil transepithelial migration. Pharmacological inhibitors of the enzymatic pathways necessary to generate hepoxilin A3, including phospholipase A2 and 12-lipoxygenase, potently interfere with P. aeruginosa-induced neutrophil transepithelial migration. Both transformed and primary human lung epithelial cells infected with P. aeruginosa generate hepoxilin A3 precursor arachidonic acid. All four known lipoxygenase enzymes capable of synthesizing hepoxilin A3 are expressed in lung epithelial cell lines, primary small airway epithelial cells, and human bronchial epithelial cells. Lung epithelial cells produce increased hepoxilin A3 and lipid-derived neutrophil chemotactic activity in response to P. aeruginosa infection. Lipid-derived chemotactic activity is soluble epoxide hydrolase sensitive, consistent with hepoxilin A3 serving a chemotactic role. Stable inhibitory structural analogs of hepoxilin A3 are capable of impeding P. aeruginosa-induced neutrophil transepithelial migration. Finally, intranasal infection of mice with P. aeruginosa promotes enhanced cellular infiltrate into the airspace, as well as increased concentration of the 12-lipoxygenase metabolites hepoxilin A3 and 12-hydroxyeicosa-5Z,8Z,10E,14Z- tetraenoic acid. Data generated from multiple models in this study provide further evidence that hepoxilin A3 is produced in response to lung pathogenic bacteria and functions to drive neutrophils across epithelial barriers.

Original languageEnglish (US)
Pages (from-to)4960-4969
Number of pages10
JournalJournal of Immunology
Volume189
Issue number10
DOIs
StatePublished - Nov 15 2012

Fingerprint

Lipoxygenase
Neutrophils
Pseudomonas aeruginosa
Epithelial Cells
Transendothelial and Transepithelial Migration
Lung
Arachidonate 12-Lipoxygenase
8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid
Lipids
Epoxide Hydrolases
Pseudomonas Infections
Phospholipases A2
Chemotactic Factors
Arachidonic Acid
Lung Diseases
Pharmacology
Bacteria
Cell Line
Acids

ASJC Scopus subject areas

  • Immunology

Cite this

Tamang, D. L., Pirzai, W., Priebe, G. P., Traficante, D. C., Pier, G. B., Falck, J. R., ... Hurley, B. P. (2012). Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. Journal of Immunology, 189(10), 4960-4969. https://doi.org/10.4049/jimmunol.1201922

Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. / Tamang, David L.; Pirzai, Waheed; Priebe, Gregory P.; Traficante, David C.; Pier, Gerald B.; Falck, J R; Morisseau, Christophe; Hammock, Bruce D.; McCormick, Beth A.; Gronert, Karsten; Hurley, Bryan P.

In: Journal of Immunology, Vol. 189, No. 10, 15.11.2012, p. 4960-4969.

Research output: Contribution to journalArticle

Tamang, DL, Pirzai, W, Priebe, GP, Traficante, DC, Pier, GB, Falck, JR, Morisseau, C, Hammock, BD, McCormick, BA, Gronert, K & Hurley, BP 2012, 'Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers', Journal of Immunology, vol. 189, no. 10, pp. 4960-4969. https://doi.org/10.4049/jimmunol.1201922
Tamang, David L. ; Pirzai, Waheed ; Priebe, Gregory P. ; Traficante, David C. ; Pier, Gerald B. ; Falck, J R ; Morisseau, Christophe ; Hammock, Bruce D. ; McCormick, Beth A. ; Gronert, Karsten ; Hurley, Bryan P. / Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. In: Journal of Immunology. 2012 ; Vol. 189, No. 10. pp. 4960-4969.
@article{bf7dd52f14ef4fb3ab0fa0242d5ec7fd,
title = "Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers",
abstract = "A feature shared by many inflammatory lung diseases is excessive neutrophilic infiltration. Neutrophil homing to airspaces involve multiple factors produced by several distinct cell types. Hepoxilin A3 is a neutrophil chemoattractant produced by pathogeninfected epithelial cells that is hypothesized to facilitate neutrophil breach of mucosal barriers. Using a Transwell model of lung epithelial barriers infected with Pseudomonas aeruginosa, we explored the role of hepoxilin A3 in neutrophil transepithelial migration. Pharmacological inhibitors of the enzymatic pathways necessary to generate hepoxilin A3, including phospholipase A2 and 12-lipoxygenase, potently interfere with P. aeruginosa-induced neutrophil transepithelial migration. Both transformed and primary human lung epithelial cells infected with P. aeruginosa generate hepoxilin A3 precursor arachidonic acid. All four known lipoxygenase enzymes capable of synthesizing hepoxilin A3 are expressed in lung epithelial cell lines, primary small airway epithelial cells, and human bronchial epithelial cells. Lung epithelial cells produce increased hepoxilin A3 and lipid-derived neutrophil chemotactic activity in response to P. aeruginosa infection. Lipid-derived chemotactic activity is soluble epoxide hydrolase sensitive, consistent with hepoxilin A3 serving a chemotactic role. Stable inhibitory structural analogs of hepoxilin A3 are capable of impeding P. aeruginosa-induced neutrophil transepithelial migration. Finally, intranasal infection of mice with P. aeruginosa promotes enhanced cellular infiltrate into the airspace, as well as increased concentration of the 12-lipoxygenase metabolites hepoxilin A3 and 12-hydroxyeicosa-5Z,8Z,10E,14Z- tetraenoic acid. Data generated from multiple models in this study provide further evidence that hepoxilin A3 is produced in response to lung pathogenic bacteria and functions to drive neutrophils across epithelial barriers.",
author = "Tamang, {David L.} and Waheed Pirzai and Priebe, {Gregory P.} and Traficante, {David C.} and Pier, {Gerald B.} and Falck, {J R} and Christophe Morisseau and Hammock, {Bruce D.} and McCormick, {Beth A.} and Karsten Gronert and Hurley, {Bryan P.}",
year = "2012",
month = "11",
day = "15",
doi = "10.4049/jimmunol.1201922",
language = "English (US)",
volume = "189",
pages = "4960--4969",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers

AU - Tamang, David L.

AU - Pirzai, Waheed

AU - Priebe, Gregory P.

AU - Traficante, David C.

AU - Pier, Gerald B.

AU - Falck, J R

AU - Morisseau, Christophe

AU - Hammock, Bruce D.

AU - McCormick, Beth A.

AU - Gronert, Karsten

AU - Hurley, Bryan P.

PY - 2012/11/15

Y1 - 2012/11/15

N2 - A feature shared by many inflammatory lung diseases is excessive neutrophilic infiltration. Neutrophil homing to airspaces involve multiple factors produced by several distinct cell types. Hepoxilin A3 is a neutrophil chemoattractant produced by pathogeninfected epithelial cells that is hypothesized to facilitate neutrophil breach of mucosal barriers. Using a Transwell model of lung epithelial barriers infected with Pseudomonas aeruginosa, we explored the role of hepoxilin A3 in neutrophil transepithelial migration. Pharmacological inhibitors of the enzymatic pathways necessary to generate hepoxilin A3, including phospholipase A2 and 12-lipoxygenase, potently interfere with P. aeruginosa-induced neutrophil transepithelial migration. Both transformed and primary human lung epithelial cells infected with P. aeruginosa generate hepoxilin A3 precursor arachidonic acid. All four known lipoxygenase enzymes capable of synthesizing hepoxilin A3 are expressed in lung epithelial cell lines, primary small airway epithelial cells, and human bronchial epithelial cells. Lung epithelial cells produce increased hepoxilin A3 and lipid-derived neutrophil chemotactic activity in response to P. aeruginosa infection. Lipid-derived chemotactic activity is soluble epoxide hydrolase sensitive, consistent with hepoxilin A3 serving a chemotactic role. Stable inhibitory structural analogs of hepoxilin A3 are capable of impeding P. aeruginosa-induced neutrophil transepithelial migration. Finally, intranasal infection of mice with P. aeruginosa promotes enhanced cellular infiltrate into the airspace, as well as increased concentration of the 12-lipoxygenase metabolites hepoxilin A3 and 12-hydroxyeicosa-5Z,8Z,10E,14Z- tetraenoic acid. Data generated from multiple models in this study provide further evidence that hepoxilin A3 is produced in response to lung pathogenic bacteria and functions to drive neutrophils across epithelial barriers.

AB - A feature shared by many inflammatory lung diseases is excessive neutrophilic infiltration. Neutrophil homing to airspaces involve multiple factors produced by several distinct cell types. Hepoxilin A3 is a neutrophil chemoattractant produced by pathogeninfected epithelial cells that is hypothesized to facilitate neutrophil breach of mucosal barriers. Using a Transwell model of lung epithelial barriers infected with Pseudomonas aeruginosa, we explored the role of hepoxilin A3 in neutrophil transepithelial migration. Pharmacological inhibitors of the enzymatic pathways necessary to generate hepoxilin A3, including phospholipase A2 and 12-lipoxygenase, potently interfere with P. aeruginosa-induced neutrophil transepithelial migration. Both transformed and primary human lung epithelial cells infected with P. aeruginosa generate hepoxilin A3 precursor arachidonic acid. All four known lipoxygenase enzymes capable of synthesizing hepoxilin A3 are expressed in lung epithelial cell lines, primary small airway epithelial cells, and human bronchial epithelial cells. Lung epithelial cells produce increased hepoxilin A3 and lipid-derived neutrophil chemotactic activity in response to P. aeruginosa infection. Lipid-derived chemotactic activity is soluble epoxide hydrolase sensitive, consistent with hepoxilin A3 serving a chemotactic role. Stable inhibitory structural analogs of hepoxilin A3 are capable of impeding P. aeruginosa-induced neutrophil transepithelial migration. Finally, intranasal infection of mice with P. aeruginosa promotes enhanced cellular infiltrate into the airspace, as well as increased concentration of the 12-lipoxygenase metabolites hepoxilin A3 and 12-hydroxyeicosa-5Z,8Z,10E,14Z- tetraenoic acid. Data generated from multiple models in this study provide further evidence that hepoxilin A3 is produced in response to lung pathogenic bacteria and functions to drive neutrophils across epithelial barriers.

UR - http://www.scopus.com/inward/record.url?scp=84868570916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868570916&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1201922

DO - 10.4049/jimmunol.1201922

M3 - Article

VL - 189

SP - 4960

EP - 4969

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -